Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM

AIDS

Volumn 27, Issue 18, 2013, Pages 2921-2931

  Aar, Fleur Van ^a   Mooij, Sofie H ^b,c   Van Der Sande, Marianne A B ^a,d   Speksnijder, Arjen G C L ^b   Stolte, Ineke G ^b   Meijer, Chris J L M ^e   Verhagen, Dominique W M ^f   King, Audrey J ^a   Vries, Henry J C De ^a,b,c   Van Der Loeff, Maarten F Schim ^b,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Department of Internal Medicine   (Netherlands)

Author keywords

Anal; Determinants; HIV; Human papillomavirus; MSM; Penile; Prevalence

Indexed keywords

VIRUS DNA;

ADULT; ANAL INTERCOURSE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONCURRENT INFECTION; DNA DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NETHERLANDS; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; SMOKING; VIRUS LOAD; ADOLESCENT; ANUS DISEASES; CLASSIFICATION; COHORT ANALYSIS; COMPLICATION; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MALE HOMOSEXUALITY; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; RISK FACTOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANUS DISEASES; COHORT STUDIES; DNA, VIRAL; GENOTYPING TECHNIQUES; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 84888287191     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000432541.67409.3c     Document Type: Article

References (41)

1. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjosé S, Kjaer SK, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 26 (Suppl 10):K17-K28.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009; 10:321-322.
3. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118:3030-3044.
4. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 2009; 124:1626-1636.
5. Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, et al. Understanding the burden of human papillomavirusassociated anal cancers in the US. Cancer 2008; 113 (10 Suppl): 2892-2900.
6. Daling JR, Weiss NS, Klopfenstein LL, Cochran LE, Chow WH, Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer. JAMA 1982; 247:1988-1990.
7. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis. Lancet Oncol 2012; 13:487-500.
8. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011; 103:753-762.
9. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101:281-288.
10. Jin F, Stein AN, Conway EL, Regan DG, Law M, Brotherton JM, et al. Trends in anal cancer in Australia, 1982-2005. Vaccine 2011; 29:2322-2327.
11. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044-1057.
12. Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM. Agespecific prevalence of human papillomavirus infection in males: A global review. J Adolesc Health 2011; 48:540-552.
13. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in Men (HIM) study. J Infect Dis 2011; 203:49-57.
14. Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010; 10:862-874.
15. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-1510.
16. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101:270-280.
17. Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, Prins M, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: A 25-year prospective cohort study. AIDS 2011; 25:493-501.
18. Heijman RL, Stolte IG, Thiesbrummel HF, van Leent E, Coutinho RA, Fennema JS, et al. Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic. Sex Transm Infect 2009; 85:249-255.
19. van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003; 17:2227-2236.
20. Molijn A, Kleter B, Quint W, Van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32 (Suppl 1):S43-S51.
21. Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS, et al. Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev 2010; 19:159-169.
22. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124:2375-2383.
23. Goldstone S, Palefsky JM, Giuliano AR, Moreira ED Jr, Aranda C, Jessen H, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis 2011; 203:66-74.
24. Kreuter A, Wieland U. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Curr Opin Infect Dis 2009; 22:109-114.
25. Tobian AA, Grabowski MK, Kigozi G, Gravitt PE, Eaton KP, Serwadda D, et al. High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda. Sex Transm Infect 2013; 89:122-127.
26. Gravitt PE. The known unknowns of HPV natural history. J Clin Invest 2011; 121:4593-4599.
27. Denny LA, Franceschi S, de Sanjosé S, Heard I, Moscicki AB, Palefsky J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 2012; 30 (Suppl 5): F168-F174.
28. Parisi SG, Cruciani M, Scaggiante R, Boldrin C, Andreis S, Dal Bello F, et al. Anal and oral human papillomavirus (HPV) infection in HIV infected subjects in northern Italy: A longitudinal cohort study among men who have sex with men. BMC Infect Dis 2011; 11:150.
29. Figliuolo G, Maia J, Jalkh AP, Miranda AE, Ferreira LC. Prevalence of and risk factors for penile infection by high-risk human papillomavirus among men infected with HIV. J Med Virol 2013; 85:413-418.
30. Guimaraes MD, Grinsztejn B, Melo VH, Rocha GM, Campos LN, Pilotto JH, et al. Anal HPV prevalence and associated factors among HIV-seropositive men under antiretroviral treatment in Brazil. J Acquir Immune Defic Syndr 2011; 57 (Suppl 3): S217-S224.
31. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009; 4:52-56.
32. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007; 165:1143-1153.
33. Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31:96-99.
34. Conley L, Bush T, Darragh TM, Palefsky JM, Unger ER, Patel P, et al. Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010; 202:1567-1576.
35. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC. Anal intraepithelial neoplasia in heterosexual and homosexual HIVpositive men with access to antiretroviral therapy. J Infect Dis 2004; 190:1685-1691.
36. De Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vezina S, Cote P, et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011; 52:1174-1181.
37. Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, et al. Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 2004; 190:2070-2076.
38. Del Amo J, Gonzalez C, Geskus RB, Torres M, Del Romero J, Vinciana P, et al. What drives the number of high risk human papillomavirus types in the anal canal in HIV-positive men who have sex with men J Infect Dis 2013; 207:1235-1241.
39. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24 (Suppl 3)S3-52-S3/61.
40. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007; 196:1146-1152.
41. Lampinen TM, Chan K, Anema A, Kornegay J, Hogg RS, Coutlee F. Self-screening for rectal sexually transmitted infections: human papillomavirus. Clin Infect Dis 2006; 42:308-309.